[RPRX]

Mid
All available information for this ticker. | View Original
Row 2026-10-01 06:08:08
Royalty Pharma EVP Marshall Urist sells $238,812 in shares
Mid 2026-08-06 01:34:58
Royalty Pharma targets $3.4B-$3.5B 2026 portfolio receipts as it raises guidance again
Row 2026-08-05 20:17:48
Royalty Pharma reports Q2 results
Row 2026-08-05 00:59:08
Royalty Pharma Q2 2026 Earnings Preview
Mid 2026-07-22 20:52:24
Royalty Pharma to pay up to $425M for royalty interest in AstraZeneca’s cliramitug
1 / 2